SST and obesity due to melanocortin 4 receptor deficiency: Another anti-obesity vaccine under development is the anti-somatostatin, which promises to remove the inhibitory effects of somatostatin on growth hormone (GH) and IGF-1 secretion, thus inhibiting the increase in adiposity associated with low levels of these hormones [138,139].